MyAverix Finance
HK · Healthcare
Simcere Pharmaceutical Group Ltd (2096)
Drug Manufacturers - Specialty & Generic
Simcere Pharmaceutical Group Ltd (2096) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $27.24B, P/E ratio is 17.10, net margin is 17.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2096
Simcere Pharmaceutical Group Ltd (2096) — FAQ
What is Simcere Pharmaceutical Group Ltd's market cap?
Simcere Pharmaceutical Group Ltd (2096) has a reported market cap of $27.24B (data as of 2026-05-21).
What is 2096's P/E ratio?
The price-to-earnings (P/E) ratio for Simcere Pharmaceutical Group Ltd (2096) is 17.10 (data as of 2026-05-21).
Does Simcere Pharmaceutical Group Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Simcere Pharmaceutical Group Ltd (2096). Check the MyAverix Finance app for the latest dividend data.
What sector is Simcere Pharmaceutical Group Ltd in?
Simcere Pharmaceutical Group Ltd (2096) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2096 listed on?
2096 is listed on HK.
What is Simcere Pharmaceutical Group Ltd's net margin?
Simcere Pharmaceutical Group Ltd (2096) reports a net margin of 17.4% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.